We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 6.00 | 0.34% | 1,795.00 | 1,794.00 | 1,796.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 1,796.00 | 1,763.00 | 1,786.00 | 111,280 | 15:14:33 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 20.54 | 3.94B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 17/4/2024 | 10:42 | UK RNS | Hikma Pharmaceuticals Plc Director/PDMR Shareholding |
| 15/4/2024 | 16:43 | UK RNS | Hikma Pharmaceuticals Plc Hikma appoints new President of Generics business |
| 11/4/2024 | 10:58 | UK RNS | Hikma Pharmaceuticals Plc Director/PDMR Shareholding |
| 02/4/2024 | 09:50 | UK RNS | Hikma Pharmaceuticals Plc Block listing Interim Review |
| 22/3/2024 | 09:21 | UK RNS | Hikma Pharmaceuticals Plc Annual Financial Report and Notice of AGM |
| 13/3/2024 | 09:42 | UK RNS | Hikma Pharmaceuticals Plc Director/PDMR Shareholding |
| 07/3/2024 | 13:52 | UK RNS | Hikma Pharmaceuticals Plc Director/PDMR Shareholding |
| 01/3/2024 | 10:17 | UK RNS | Hikma Pharmaceuticals Plc Total Voting Rights |
| 22/2/2024 | 09:42 | ALNC |  TOP NEWS: Hikma boosts dividend after year of "significant progress" |
| 22/2/2024 | 07:09 | ALNC | *Hikma Pharmaceuticals says core operating profit to be in range of USD660m.. |
1 Year Hikma Pharmaceuticals Chart |
Intraday Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
